An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Novanta Inc. (NASDAQ:NOVT) announced that Matthijs Glastra, Chairperson and CEO, along with CFO Robert Buckley, will present at the J.P. Morgan Healthcare Conference on January 11, 2022, in San Francisco, California. As a leading global supplier of core technology solutions, Novanta enables medical and advanced industrial OEMs to achieve a competitive advantage through its expertise in photonics, vision, and precision motion. The company focuses on delivering high-performance components tailored to demanding applications, driven by a commitment to innovation and customer success.
Positive
None.
Negative
None.
BEDFORD, Mass.--(BUSINESS WIRE)--
Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference, which is being held in person, on Tuesday, January 11, 2022, in San Francisco, California.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT”.
More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.
